C

Cannabist Company Holdings Inc
NEO:CBST

Watchlist Manager
Cannabist Company Holdings Inc
NEO:CBST
Watchlist
Price: 0.085 CAD -10.53% Market Closed
Market Cap: 184.4m CAD

Relative Value

The Relative Value of one CBST stock under the Base Case scenario is 0.341 CAD. Compared to the current market price of 0.085 CAD, Cannabist Company Holdings Inc is Undervalued by 75%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CBST Relative Value
Base Case
0.341 CAD
Undervaluation 75%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
88
Median 3Y
0.4
Median 5Y
0
Industry
2.6
Forward
0.4
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
0
Industry
21.7
Forward
-0.6
vs History
vs Industry
Median 3Y
-6.6
Median 5Y
0
Industry
16.7
vs History
vs Industry
Median 3Y
-7.9
Median 5Y
0
Industry
23.1
vs History
vs Industry
12
Median 3Y
6
Median 5Y
-1.8
Industry
2.2
vs History
30
vs Industry
76
Median 3Y
1.2
Median 5Y
0
Industry
2.9
Forward
1.4
vs History
28
vs Industry
68
Median 3Y
3.5
Median 5Y
0
Industry
5.5
vs History
vs Industry
40
Median 3Y
12.2
Median 5Y
0
Industry
13.2
Forward
15.9
vs History
vs Industry
Median 3Y
-74.5
Median 5Y
0
Industry
16.8
Forward
-11.1
vs History
vs Industry
Median 3Y
-21.6
Median 5Y
0
Industry
15.9
vs History
vs Industry
Median 3Y
-187.4
Median 5Y
0
Industry
19.2
vs History
47
vs Industry
73
Median 3Y
1.4
Median 5Y
0.8
Industry
1.9

Multiples Across Competitors

CBST Competitors Multiples
Cannabist Company Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cannabist Company Holdings Inc
NEO:CBST
206.1m CAD 0.3 -0.8 -165.1 -11.4
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55.3 37.1 39.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
258.9B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
211.4B GBP 4.9 30.3 109 159.6
CH
Novartis AG
SIX:NOVN
208.6B CHF 4.7 18.3 11.6 15
US
Merck & Co Inc
NYSE:MRK
260.5B USD 4.1 13.7 9.7 11.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.3 13 9.1 10.6
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143.3B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
US
C
Cannabist Company Holdings Inc
NEO:CBST
Average P/E: 24.1
Negative Multiple: -0.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.3
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.3
38%
0.8
CH
Novartis AG
SIX:NOVN
18.3
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.7
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13
4%
3.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
C
Cannabist Company Holdings Inc
NEO:CBST
Average EV/EBITDA: 438.9
Negative Multiple: -165.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.1
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
109
10%
10.9
CH
Novartis AG
SIX:NOVN
11.6
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.7
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.1
2%
4.5
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
C
Cannabist Company Holdings Inc
NEO:CBST
Average EV/EBIT: 1 881.4
Negative Multiple: -11.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.8
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
159.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.5
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.6
1%
10.6
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3